Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Pregabalin I.P. 75mg (S.R.) Tablet
Therapeutic Category
Antiepileptic, Neurology
Dosage Form
Tablet
Packaging Type
Alu Alu
Packaging
10*10
Price
₹499/-
High-resolution images and Product visuals
Product overview and usage information
Detailed information and research documents
Pregahike 75 SR contains Pregabalin I.P. 75mg in a sustained-release (S.R.) formulation. Pregabalin is a well-established medication commonly prescribed for the treatment of various neurological and psychological conditions. The sustained-release (S.R.) formulation ensures a gradual release of the medication over time, leading to a longer-lasting effect and improved compliance for patients.
Pregahike 75 SR works by calming overactive nerve activity and stabilizing electrical activity in the brain. It is particularly effective in treating nerve-related pain and certain types of seizures. This medication is also used to alleviate symptoms of generalized anxiety disorder (GAD), offering significant relief to individuals experiencing anxiety.
Common side effects include dizziness, drowsiness, weight gain, and swelling. Serious side effects may include mood changes, difficulty breathing, or suicidal thoughts.
Pregahike 75 SR is indicated for neuropathic pain, partial seizures (in combination with other anticonvulsants), and generalized anxiety disorder (GAD).
Use as prescribed by your doctor and avoid alcohol. Consult a healthcare provider if pregnant or breastfeeding.
Store in a cool, dry place, away from sunlight and moisture, and out of reach of children.
Composition : Paroxetine I.P. 12.5mg Prolonged Release Tablets
Composition : Paroxetine I.P. 25mg Prolonged Release Tablets
Composition : Quetiapine Fumarate I.P. 100mg Tablet
Composition : Quetiapine Fumarate I.P. 25mg Tablet
Composition : Quetiapine Fumarate I.P. 50mg Tablet
Composition : Sertraline 100mg Tablet
Composition : Sertraline 25mg Tablet
Composition : Sertraline 50mg Tablet
Composition : Amisulpride 100mg Tablet
Composition : Amisulpride 200mg Tablet
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
Pregabalin (S.R.) Tablets have strong demand in the neurology and pain management segment, making them a high-growth product for pharma distributors, wholesalers, and franchise partners. It is widely prescribed for neuropathic pain, diabetic neuropathy, fibromyalgia, and anxiety-related conditions, ensuring consistent chronic prescription-based demand.
Medical distributors and agencies benefit from the high-volume chronic pain and neuropathy treatment market. Used for neuropathic pain management (diabetic neuropathy, nerve pain, radiculopathy) Helps reduce burning sensation, tingling, and nerve-related pain symptoms Commonly prescribed by neurologists, orthopedicians, and physicians Sustained Release (SR) formulation ensures longer duration of action and better compliance Also used in anxiety disorders and sleep-related neuropathic discomfort (as per physician guidance) Ensures repeat monthly prescriptions due to long-term therapy requirement This makes it a strong, fast-moving CNS and pain management product.
Yes, Cafoli LifeCare Pvt Ltd offers PCD pharma franchise opportunities for Pregabalin 75 mg (S.R.) Tablets with monopoly rights, promotional support, quality manufacturing standards, attractive packaging, and competitive pricing for distributors and wholesalers.
Wholesalers and franchise partners benefit from consistent chronic pain prescription demand, strong neurologist and physician market coverage, repeat monthly sales, and stable long-term growth in the neurology segment.
Interested distributors, stockists, and pharma franchise partners can contact Cafoli LifeCare Pvt Ltd to discuss monopoly territory rights, pricing structure, marketing support, and complete neurology product portfolio access to build a strong presence in the pain management and CNS market.